Status: Not yet recruiting
COLON ERDERLY LOW DOSE
In this retrospective observational study, the case series of patients undergoing first-line treatment for metastatic colorectal adenocarcinoma with doublet fixed-dose and reduced-dose chemotherapy in combination with full-dose monoclonal antibody in patients aged 70 years or older is collected.
Participants needed: 51
Trial details
Age: 70-99Biological sex: AllType: ObservationalSponsor: Matteo ClavarezzaUpdated: Feb 2, 2026Locations: 1
Eligibility criteria
Patients with metastatic colorectal adenocarcinoma not treated with any therapy... [+5]
Patients with MSI tumours [+2]